mrc

  • Home
  • About Us
  • Vacancies
  • Sitemap
  • Contact Us
+44 (0)20 7391 2700
  • Commercial Opportunities
  • Info for Researchers
  • TTOs & Academic Collaborations
  • News
  • How we work
    • Intellectual Property and Licensing
    • Business Development
    • Centre for Therapeutics Discovery
    • Centre for Lifescience Technologies
    • Corporate Partnerships
  • History
  • Facts and Figures
  • Governance
    • MRCT Board
    • CEO and Executive Directors
  • Company information
  • Vacancies
  • Contact
  • Downloads

Company information

Registered address

Lynton House, 7-12 Tavistock Square, London WC1H 9LT

Company number

Medical Research Council Technology is a company limited by guarantee no. 2698321 incorporated in England and Wales.

Charity numbers

Medical Research Council Technology is a charity registered with the Charity Commission for England and Wales no. 1015243 and a charity registered in Scotland with the Office of the Scottish Charity Regulator no. SC037861.

Print Pdf Twitter Rss


News feed

  • MRCT are collaborating with the University of Bristol to develop orally available small molecule TrkA antagonists for treatment of chronic intractable pain.

  • MRC Technology’s Therapeutic Antibody Group and The University of Aberdeen work together on project to develop therapeutic against a novel cancer target, soluble CTLA-4.

  • Aptuscan, a spin out company based on research carried out at the MRC Cancer Cell Unit, has been acquired by Avacta, an AIM-listed biotechnology company.

  • MRC Technology announced today that they have entered into an agreement with the Association for International Cancer Research (AICR) to assist in the oversight and management of intellectual property (IP) arising from AICR-funded projects.

  • Downloads
  • News, Events and Press Releases
  • Follow us on Twitter
Change Font Size A A
  • About us
  • Vacancies
  • Contact Us
  • Sitemap
  • Legal Information
Copyright MRC Technology 2011